The Recall Desk
ModerateFDA (Devices)·Z-1130-2015·Announced 2015-02-25

Haemonetics TEG Hemostasis System Level II Control Recall

Haemonetics is recalling specific lots of TEG Hemostasis System Level II Control kits because they produce high Maximum Amplitude results outside the expected quality control range.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any hospitalizations, injuries, or illnesses, fitting the criteria for a moderate severity score.

Plain-English summary

Haemonetics Corporation is recalling 4,143 kits of the TEG Hemostasis System Level II Control, catalog number 8002. This product is a biological control used with the Thrombelastograph (TEG) Hemostasis System.

The recall is being issued because specific lots of these control kits produce high Maximum Amplitude (MA) results. These results fall outside of the manufacturer's expected Quality Control range for the MA parameter.

The affected lots are HMO 9200, HMO 9217, HMO 9226, HMO 9232, HMO 9276, HMO 9285, and HMO 9292, all with an expiration date of 1/2017. The products were distributed worldwide, including in the US, Canada, Czech Republic, Denmark, Great Britain, and Sweden. Users should stop using the affected lots and contact Haemonetics Corporation for further instructions.

The recalled product

Product
Haemonetics TEG Hemostasis System Level II Control, Catalog number: 8002. Level II Control is a biological control for use with the Thrombelastograph (TEG) Hemostasis System.
Affected units
4,143

Distribution

Distribution scope not specified by the agency.